Advance Mandatory Product Listing
CRN strongly supports the creation of a mandatory product listing (MPL) housed at FDA to provide transparency to regulators, retailers and consumers alike. We will redouble our efforts to enact federal legislation to establish an MPL for dietary supplements in the U.S. market.
Also, learn about how the Supplement OWL is a model for product listing.
Catch up on CRN's thought leadership when it comes to MPL in the articles below:
Stop the sale of bogus supplements as a cure or treatment for COVID-19
by Julia Gustafson with Liz Richardson of The Pew Charitable Trusts in The Hill
A Mandatory Dietary Supplement Registry: Transparency as ‘disinfectant’
by Steve Mister in RAPS Regulatory Focus
Mandatory Product Listing: Beneficial, or Burdensome?
by Steve Mister in WholeFoods Magazine